Post-Acute COVID-19 Clinical Trials
2 recruiting trials for Post-Acute COVID-19. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Post-Acute COVID-19 clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by First Affiliated Hospital Xi'an Jiaotong University (1), Columbia University (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Simultaneous cortico-spinal magnetic resonance imaging, Serum (device, 1 trial), followed by Structured mindfulness intervention.
Track Post-Acute COVID-19 trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Cohort Follow-up of Epidemic and Neuroimaging for Patients During the 1st Wave of the COVID-19 in China
Our main objective is to analyze the development of physical impact, mental health and blood profile over follow-up time during the 1st wave of the COVID-19. Besides, we aim to...
Long-Covid-19 Alleviation Through Learning Mindfulness Study
This research is being done to study a mindfulness intervention among people who have symptoms of Post-Acute Sequelae of SARS-CoV-2 infection (PASC), also known as Long COVID....
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Post-Acute COVID-19, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Post-Acute COVID-19, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Post-Acute COVID-19, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.